RxDoctor Payments DataLook up a doctor →

Varshasb Broumand, MD

Nephrology · San Antonio, TXNPI 1154329720

Payments from drug & device makers

$537,766in general payments, 2019–2025

Across 1,089 payments — averaging $493.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Akebia Therapeutics Inc$187K
  • Grifols, S.A.$136K
  • GSK$94K
  • Outset Medical Inc$43K
  • OPKO Pharmaceuticals, LLC$34K
  • AstraZeneca$11K
  • plus $33K from 40 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Akebia Therapeutics Inc170$187,328
Grifols, S.A.20$136,453
GSK48$93,868
Outset Medical Inc29$42,900
OPKO Pharmaceuticals, LLC214$33,631
AstraZeneca(2 entities)50$10,876
Vifor Pharma, Inc.38$9,420
Bayer52$9,090
Amgen(2 entities)88$5,748
Fresenius USA Marketing, Inc.59$944
Travere Therapeutics, Inc.28$888
Mallinckrodt Hospital Products Inc.38$839
AbbVie(2 entities)64$720
Novartis29$551
Calliditas Therapeutics US Inc.21$469
Otsuka America Pharmaceutical, Inc.15$436
Mallinckrodt Enterprises LLC14$402
Bard Peripheral Vascular, Inc.12$366
Novo Nordisk14$361
Aurinia Pharma U.S., Inc.11$344
ANI Pharmaceuticals, Inc.15$307
W. L. Gore & Associates, Inc.6$233
Lilly USA, LLC6$204
Ardelyx, Inc.8$201
Shield Therapeutics Inc8$148
Cormedix Inc.4$143
Corcept Therapeutics1$125
Angiodynamics, Inc.2$116
Sonavex, Inc.1$87
Nxstage Medical, Inc.2$69
Keystone Dental Inc.1$69
Boehringer Ingelheim3$63
Omeros Corporation1$52
Amarin Pharma, Inc.3$43
Sanofi2$37
Amicus Therapeutics, Inc.2$35
Apellis Pharmaceuticals, Inc.1$29
Takeda Pharmaceuticals U.S.A., Inc.1$25
Organogenesis Inc.1$25
Argon Medical Devices, Inc.1$24
Arbor Pharmaceuticals, Inc.1$22
Daiichi Sankyo Inc.1$22
Cook Medical LLC1$21
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$14
Strongbridge US Inc.1$12
Cardiovascular Systems Inc.1$9

How this compares

$537,766 in reported general payments places this provider in the 95th percentile of 1,070 nephrology providers in Texas.

See all nephrology providers in Texas →

Medicare billing

Part B allowed, 2024
$229,244
Medicare patients
472
Services billed
1,920

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in San Antonio

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →